Intellectual Property India Publishes Patent Application for 'Biarylamide Derivatives And Their Use As Pkmyt1 Inhibitors' Filed by Cancer Research Technology Limited; and My-T Bio Limited

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202547097015 A) filed by Cancer Research Technology Limited; and My-T Bio Limited, London, on Oct. 8, for 'biarylamide derivatives and their use as pkmyt1 inhibitors.'

Inventor(s) include Raoof, Ali; Spyridon-Gavriil, Efthymios; Niculescu-Duvaz, Dan; Brown, Michaelepo; Smithen, Deborah; Fitzpatrick, Christopher; Grytsai, Oleksandr; Aljarah, Mohammed; Lisauskaite, Monika; Burgin, Ryan; Kershaw, Christopher Stephen; Leung, Leo; Hagan, Iain; Marais, Richard; and Springer, Caroline.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The present inventi...